Astria Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATXS and other ETFs, options, and stocks.About ATXS
Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway.
CEOJill C. Milne
CEOJill C. Milne
Employees78
Employees78
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2008
Founded2008
Employees78
Employees78
ATXS Key Statistics
Market cap247.75M
Market cap247.75M
Price-Earnings ratio-2.61
Price-Earnings ratio-2.61
Dividend yield—
Dividend yield—
Average volume477.11K
Average volume477.11K
High today$4.51
High today$4.51
Low today$4.21
Low today$4.21
Open price$4.43
Open price$4.43
Volume867.92K
Volume867.92K
52 Week high$12.92
52 Week high$12.92
52 Week low$3.56
52 Week low$3.56
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ATXS. This list is generated using Robinhood data, and it’s not a recommendation.